[HTML][HTML] Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer …
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …
[HTML][HTML] Complications related to transarterial treatment of hepatocellular carcinoma: a comprehensive review
HN Lee, D Hyun - Korean Journal of Radiology, 2023 - ncbi.nlm.nih.gov
Currently, various types of transarterial treatments are performed for hepatocellular
carcinoma from the early to advanced stages. Its indications and efficacy have been widely …
carcinoma from the early to advanced stages. Its indications and efficacy have been widely …
Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based …
X Zhang, Z He, Y Zhang, J Kong - Frontiers in Pharmacology, 2024 - frontiersin.org
Objective: A prognostic model utilizing CT radiomics, radiological, and clinical features was
developed and validated in this study to predict an objective response to initial transcatheter …
developed and validated in this study to predict an objective response to initial transcatheter …
[HTML][HTML] Tumor diameter and enhancing capsule, as well as previous interventional treatments, as potential predictors of vascular lake phenomenon in hepatocellular …
K Hatakeyama, T Tozawa, Y Wada… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Objectives: The initial drug-eluting bead (DEB)-transarterial chemoembolization (TACE) are
often performed after multiple sessions of transarterial infusion chemotherapy (TAI) or …
often performed after multiple sessions of transarterial infusion chemotherapy (TAI) or …
[HTML][HTML] Interruption during drug-eluting beads transarterial chemoembolization procedure by presumed allergic shock requires careful follow-up on the development …
A Ogawa, Y Wada, K Iijima, N Mori - Journal of Clinical Imaging …, 2024 - ncbi.nlm.nih.gov
We present a case involving a 60-year-old male with multifocal hepatocellular carcinoma
(HCC), emphasizing the critical need for vigilant post-procedural monitoring following the …
(HCC), emphasizing the critical need for vigilant post-procedural monitoring following the …
The Incidences and Related CT Features of Vascular Lake Phenomenon on Angiography Before Chemoembolization
KL Yang, YP Guo, XY Mao, J Shen, JW Zou… - CardioVascular and …, 2024 - Springer
Purpose To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular
carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on …
carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on …
アテゾリズマブとベバシズマブの併用療法に伴う腫瘍内の出血壊死により治療継続が困難となったHBV 関連大型肝細胞癌の一例
松本萌， 則武秀尚， 山下真帆， 花岡智彦， 梅村昌宏… - 肝臓, 2023 - jstage.jst.go.jp
抄録 アテゾリズマブとベバシズマブの併用療法は切除不能な肝細胞癌に対して有効である.
我々はこれらの併用で治療効果を認めながらも腫瘍内の出血壊死により治療中止となった HBV …
我々はこれらの併用で治療効果を認めながらも腫瘍内の出血壊死により治療中止となった HBV …